Literature DB >> 34690594

Late Life Depression: The Essentials and the Essential Distinctions.

Sehba Husain-Krautter1, James M Ellison1.   

Abstract

Late life depression (LLD), a familiar syndrome, is not differentiated in the DSM-5. LLD can resemble depressive syndromes in younger adults but it differs in demographic characteristics, phenomenology, prognosis, treatment, suicide risk, relationship to other disorders, and etiology. Older depressed adults often present with fewer major depressive symptoms, less emphasis on mood disturbance, greater preoccupation with somatic or psychotic symptoms, and misleading cognitive deficits. LLD's relationships with medical and neurocognitive symptoms and with inflammatory and immune factors are complex. Formal screening tools and biopsychosocial assessment informs diagnosis and treatment. Evidence supports the effectiveness of lifestyle interventions, several psychotherapies, and a variety of somatic treatment approaches. Comorbid medical disorders must be taken into account when planning treatment. In this article, the authors describe the characteristics of LLD, present an approach to assessment and management, and recommend that future DSM editions include a new specifier to differentiate LLD from other depressive syndromes.
Copyright © 2021 by the American Psychiatric Association.

Entities:  

Keywords:  Depression; Geriatric psychiatry

Year:  2021        PMID: 34690594      PMCID: PMC8475940          DOI: 10.1176/appi.focus.20210006

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  112 in total

1.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Authors:  Eric J Lenze; Benoit H Mulsant; Daniel M Blumberger; Jordan F Karp; John W Newcomer; Stewart J Anderson; Mary Amanda Dew; Meryl A Butters; Jacqueline A Stack; Amy E Begley; Charles F Reynolds
Journal:  Lancet       Date:  2015-09-27       Impact factor: 79.321

2.  Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial.

Authors:  Amit Dias; Fredric Azariah; Stewart J Anderson; Miriam Sequeira; Alex Cohen; Jennifer Q Morse; Pim Cuijpers; Vikram Patel; Charles F Reynolds
Journal:  JAMA Psychiatry       Date:  2019-01-01       Impact factor: 21.596

3.  Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.

Authors:  Elaine Setiawan; Sophia Attwells; Alan A Wilson; Romina Mizrahi; Pablo M Rusjan; Laura Miler; Cynthia Xu; Sarita Sharma; Stephen Kish; Sylvain Houle; Jeffrey H Meyer
Journal:  Lancet Psychiatry       Date:  2018-02-26       Impact factor: 27.083

Review 4.  Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis.

Authors:  M Luppa; C Sikorski; T Luck; L Ehreke; A Konnopka; B Wiese; S Weyerer; H-H König; S G Riedel-Heller
Journal:  J Affect Disord       Date:  2010-12-30       Impact factor: 4.839

Review 5.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

6.  Late-life and life history predictors of older adults' high-risk alcohol consumption and drinking problems.

Authors:  Rudolf H Moos; Kathleen K Schutte; Penny L Brennan; Bernice S Moos
Journal:  Drug Alcohol Depend       Date:  2009-12-06       Impact factor: 4.492

7.  Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

Authors:  F K Goodwin; A J Prange; R M Post; G Muscettola; M A Lipton
Journal:  Am J Psychiatry       Date:  1982-01       Impact factor: 18.112

8.  General medical with depression drugs associated.

Authors:  Donald Rogers; Ronald Pies
Journal:  Psychiatry (Edgmont)       Date:  2008-12

9.  The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study.

Authors:  Reinhard Heun; Antti Ahokas; Patrice Boyer; Natalia Giménez-Montesinos; Fernando Pontes-Soares; Valérie Olivier
Journal:  J Clin Psychiatry       Date:  2013-06       Impact factor: 4.384

Review 10.  Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications.

Authors:  Peter L Franzen; Daniel J Buysse
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more
  1 in total

Review 1.  Pathomechanisms of Vascular Depression in Older Adults.

Authors:  Kurt A Jellinger
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.